Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,840.78 -36.27 (-0.46%) Bitcoin USD
65,317.54 +3,437.89 (+5.56%) CMC Crypto 200
1,344.08 +31.45 (+2.46%)
Merck & Co., Inc. (MRK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 317.21B |
| Enterprise value | 345.17B |
| Trailing P/E | 894.50 |
| Forward P/E | 14.62 |
| PEG ratio (5-yr expected) | 0.10 |
| Price/sales (ttm) | 5.31 |
| Price/book (mrq) | 8.44 |
| Enterprise value/revenue | 5.74 |
| Enterprise value/EBITDA | 49.97 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.40 |
| 52-week change 3 | 8.55% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 133.10 |
| 52-week low 3 | 99.14 |
| 50-day moving average 3 | 126.05 |
| 200-day moving average 3 | 112.57 |
Share statistics
| Avg vol (3-month) 3 | 8.31M |
| Avg vol (10-day) 3 | 6M |
| Shares outstanding 5 | 2.53B |
| Implied shares outstanding 6 | 2.53B |
| Float 8 | 2.53B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 78.57% |
| Shares short (28 Mar 2024) 4 | 19.59M |
| Short ratio (28 Mar 2024) 4 | 1.77 |
| Short % of float (28 Mar 2024) 4 | 0.77% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.77% |
| Shares short (prior month 29 Feb 2024) 4 | 16.6M |
Dividends & splits
| Forward annual dividend rate 4 | 3.08 |
| Forward annual dividend yield 4 | 2.46% |
| Trailing annual dividend rate 3 | 2.92 |
| Trailing annual dividend yield 3 | 2.33% |
| 5-year average dividend yield 4 | 2.89 |
| Payout ratio 4 | 2,114.29% |
| Dividend date 3 | 05 Apr 2024 |
| Ex-dividend date 4 | 14 Mar 2024 |
| Last split factor 2 | 1048:1000 |
| Last split date 3 | 03 Jun 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.61% |
| Operating margin (ttm) | 0.08% |
Management effectiveness
| Return on assets (ttm) | 2.64% |
| Return on equity (ttm) | 0.90% |
Income statement
| Revenue (ttm) | 60.12B |
| Revenue per share (ttm) | 23.69 |
| Quarterly revenue growth (yoy) | 5.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 8.3B |
| Net income avi to common (ttm) | 365M |
| Diluted EPS (ttm) | 0.14 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 7.09B |
| Total cash per share (mrq) | 2.8 |
| Total debt (mrq) | 36.27B |
| Total debt/equity (mrq) | 96.37% |
| Current ratio (mrq) | 1.25 |
| Book value per share (mrq) | 14.85 |
Cash flow statement
| Operating cash flow (ttm) | 13.01B |
| Levered free cash flow (ttm) | 2.13B |
© 2024 Yahoo. All rights reserved.